Apex Biotechnology Corp.

Taiwan Stock Exchange 1733.TW

Apex Biotechnology Corp. Dividend Yield on January 14, 2025: 5.04%

Apex Biotechnology Corp. Dividend Yield is 5.04% on January 14, 2025, a 18.10% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Apex Biotechnology Corp. 52-week high Dividend Yield is 5.39% on August 06, 2024, which is 6.92% above the current Dividend Yield.
Apex Biotechnology Corp. 52-week low Dividend Yield is 3.91% on April 08, 2024, which is -22.38% below the current Dividend Yield.
Apex Biotechnology Corp. average Dividend Yield for the last 52 weeks is 4.72%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

Taiwan Stock Exchange: 1733.TW

Apex Biotechnology Corp.

CEO	Dr. Thomas Y. S. Shen Ph.D.
IPO Date	June 14, 2000
Location	Taiwan
Headquarters	No. 7, Li-Hsin 5th Road
Employees	641
Sector	Health Care
Industries Biotechnology Medical Instruments Pharmaceuticals

Description

Apex Biotechnology Corp. engages in the research, development, manufacture, and sale of home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing, and hemoglobin screening systems. It also provides pesticide residues check systems; and care management and tele-health services. The company was founded in 1997 and is headquartered in Hsinchu City, Taiwan.

Key trends

Past 5 years